New research suggests that a procedure now regarded as Plan B when patients have episodes of rapid heartbeat after a ...

Tirzepatide is a long-acting dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist ...

The Centre for Chronic Disease Control (CCDC) announced the completion of the Treatment Optimization for Blood Pressure with Single-Pill Combinations in India (TOPSPIN) Study, a research initiative ...

Lilly's drug is the only oral treatment in a field of several injectable therapies being tested to treat high Lp(a), a risk factor for heart disease that affects one in five individuals globally ...

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

"Patients who require diuretic treatment for swelling associated with chronic heart failure and liver disease may now have a new, self-administered option, particularly when they are unable to take ...

CHICAGO -- Gene therapy for Danon disease, a rare inherited cause of hypertrophic cardiomyopathy, appeared to improve or ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among ...

Ablation, a procedure to treat abnormal electrical short circuits caused by a heart attack and is usually reserved for ...

Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

But the incumbents look set to fight to hold on to the market, with Alnylam Pharmaceuticals sharing early-phase data on its ...

The study also did not determine which patients with particular characteristics would benefit more from one treatment or the other. "In addition, these results cannot be generalized to patients who ...